This trial is for patients with 1-6 brain metastases who will receive neo-adjuvant stereotactic radiosurgery.
1 Primary · 5 Secondary · Reporting Duration: 5 years
30 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: